doi: 10.3389/fmicb.2024.1446595 Received 10 June 2024 Accepted 02 August 2024 Published 14 August 2024 Volume 15 - 2024 Edited by Daniela De Biase, Sapienza University of Rome, Italy Reviewed by Wolfgang Buckel, University of Marburg, Germany Malte Sinn, University of Konstanz, Germany Updates Copyright 2024 Piskol, Lukat, Kaufhold, Heger, Blankenfeldt, Jahn and Moser
However, it has not received approval as a medical product from the US Food and Drug Administration (FDA), and studies on its use in humans are lacking
Learn more about our Employee Benefits Consulting services: Why GLP-1 Coverage Has Become Such a Big Issue GLP-1 medications can cost hundreds of dollars per month after rebates and manufacturer discounts, with utilization continuing to increase across employer-sponsored health plans
Some adverse effects reported were irritation of nasal passages, headaches, and a bloody nose
Risk of Thyroid Tumors One of the most concerning long-term risks associated with Ozempic is the potential for thyroid tumors, including medullary thyroid carcinoma (MTC)